4UHRY Z,COLONNA M,REMONTET L,et al.Estimating infra-national and national thyroid cancer incidence in France from can-cer registries data and national hospital discharge database[J].Eur J Epidemiol,2007,22(9):607-614.
5CAPEZZONE M,MORABITO E,BELLITTI P,et al.Increasing incidence of thyroid cancer in Basilicata:an Italian study[J].J Endocrinol Invest,2007,30(6):507-512.
6CARTER W B,TOURTELOT J B,SAVELL J G,et al.New treatments and shifting paradigms in differentiated thyroid cancer management[J].Cancer Control,2011,18(2):96-103.
8KANAVAROS P,STEFANAKI K.Immunhistochemical expression of p53,p21/wafl,rb,p16,cyelinD1,p27,Ki67,cyclinA,cyclinB1,bcl-2,bax and bak proteins and apoptotic index in normal thymus[J].Histopathol,2001,16(4):1005-1012.
9YIN X M,OLTVAI Z N,KORSMEYER S J.BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax[J].Nature,1994,369(6478):321-323.
10KONOPLEVA M,TARI AM,ESTROV Z,et al.Liposomal Bcl-2 antisense oligonucleotides enhance proliferation,sensitize acute myeloid leukemia to cytosine-arabinoside,and induce apoptosis independent of other antiapoptotic proteins[J].Blood,2000,95(12):3929-3938.
